La vendita allo scoperto per Surgery Partners dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Surgery Partners. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Surgery Partners (NASDAQ:SGRY) Azioni, Report sulle vendite allo scoperto

SURGERY PARTNERS INC

Surgery Partners

Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.

<p><i><strong>A new EV destination in Laval, designed and built by MONTONI</strong></i></p>
<p>LAVAL, QC, July 16, 2025 /CNW/ - Electric-vehicle manufacturer Rivian, in partnership with Montoni Group, held a groundbreaking ceremony today marking the official start of construction on its new service centre in Québec. The event, held in Laval, was attended by the city's mayor, Stéphane Boyer. The planned facility is a key step in the expansion of Rivian's Canadian operations and speaks to the company's commitment to better serving its Québec customers.</p>
<p>Rivian's project in Laval addresses a concrete need for a permanent service point that is accessible and conveniently located for Québec drivers, with construction entrusted to local partners and talent.</p>


News

Global

RIVN

Rivian In Partnership With Montoni, Breaks Ground On New EV Service Center In Laval, Québec

WIIM

GMAB

Genmab shares are trading higher after the company reported Q2 net sales of DARZALEX totaling $3.539B.

<p>JP Morgan  analyst Jessica Fye   maintains Halozyme Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HALO#NASDAQ">HALO</a>) with a Neutral and raises the price target from $58 to $60.</p>


Price Target

Analyst Ratings

HALO

JP Morgan Maintains Neutral on Halozyme Therapeutics, Raises Price Target to $60

<p><a href="https://news.gm.com/home.detail.html/Pages/news/us/en/2025/jul/0716-GM-Redwood-Materials-pursue-use-US-built-batteries-energy-storage.html">https://news.gm.com/home.detail.html/Pages/news/us/en/2025/jul/0716-GM-Redwood-Materials-pursue-use-US-built-batteries-energy-storage.html</a></p>


General

'GM and Redwood Materials to pursue use of U.S.-built batteries for energy storage'

<p><strong>Citigroup </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) has <a target="_blank" href="https://www.benzinga.com/topic/banks" rel="noreferrer noopener">kicked off</a> earnings season with strong second-quarter 2025 results, prompting several Wall Street analysts to reiterate positive ratings and raise price forecasts for the banking giant.</p>
<p>The company&#8217;s performance was highlighted by an impressive beat on earnings per share and net interest income, driven by robust activity in its Markets and Services segments, along with disciplined expense management.</p>
<p>Analysts from <strong>Piper Sandler</strong>, <strong>UBS</strong>, and <strong>Keefe, Bruyette &amp; Woods</strong> lauded Citi&#8217;s improved outlook, significant capital returns, and a clearer path towards achieving its return on tangible common equity (ROTCE) targets, despite the stock trading slightly lower on Wednesday following the initial report.</p>
<p><strong><em>Also Read: <a target="_blank" href="https://www.benzinga.com/markets/earnings/25/07/46417779/citigroup-q2-revenue-and-profit-jumps-cfo-says-recession-risk-has-fallen" rel="noreferrer noopener">Citigroup Q2 Revenue And Profit Jumps, CFO Says Recession Risk Has Fallen</a></em></strong></p>
<p>Piper Sandler&#8217;s Scott Siefers maintained an Overweight rating, increasing his price forecast from $84 to $104. UBS analyst Erika Najarian <a href="https://www.benzinga.com/quote/C/analyst-ratings" target="_blank" rel="noreferrer noopener">reiterated</a> a Neutral rating with a price forecast of $89. Meanwhile, Keefe, Bruyette &amp; Woods analyst Christopher McGratty reiterated a Buy rating, setting a price forecast of $105. These analysts highlighted various factors contributing to their optimism.</p>
<h2 class="wp-block-heading"><strong>Piper Sandler</strong></h2>
<p>Following Citigroup&#8217;s strong second-quarter fiscal 2025 earnings and updated guidance, Siefers raised his EPS estimates. The analyst increased his 2025 EPS forecast from $7.26 to $7.30 and 2026 EPS from $9.27 to $9.46.</p>
<p>He noted that Citigroup looks poised to emerge as one of this quarter&#8217;s standout performers. Core results came in above expectations, especially on NII, which rose 8.3% quarter-over-quarter, and expenses, which grew just 1.3% quarter-over-quarter, Siefers noted. </p>
<p>While credit costs of $2.8 billion were $90 million above the analyst&#8217;s forecast, and noninterest revenue missed by $136 million (mainly due to overestimating Markets), investment banking beat expectations, offsetting the shortfall.</p>
<p>Even after a strong year-to-date rally across universal banks, Citigroup remains the best value, trading at 96% of tangible book value (P/TBV), the only major bank still below TBV, Siefers noted. The analyst continues to see meaningful upside, supported by positive operating leverage, more substantial capital returns, and a more straightforward path to achieving 10%-11% ROTCE by 2026.</p>
<h2 class="wp-block-heading"><strong>UBS</strong></h2>
<p>Citigroup delivered second-quarter fiscal 2025 EPS of $1.96, well above Najarian&#8217;s estimate of $1.64 and the consensus estimate of $1.63. She noted that the bank reported net interest income (NII) of $15.2 billion, beating expectations by about $1.2 billion, or roughly 50 cents per share. According to the analyst, the bulk of the NII upside came from Markets (about $900 million) and Services (around $200 million).</p>
<p>Although fee income came in lower than expected, the shortfall appears tied to FICC trading geography, where NII offset weaker fee performance, Najarian noted. Total Markets outperformed by 17 cents, led by FICC strength (+14 cents). In comparison, investment banking added 2 cents above expectations, driven by solid advisory and ECM performance, areas where Citi has not historically led compared to its DCM dominance, as per the analyst.</p>
<p>She noted that operating expenses came in 2 cents below forecast, and provisions were 3 cents lighter than expected. Citigroup now guides to the higher end of its previous revenue range at ~$84 billion, with full-year expenses projected at $53.4 billion, Najarian said. While consensus already reflects those figures, the analyst noted that strong PPNR (pre-provision net revenue) adds to the stock&#8217;s appeal, even amid crowded long positioning.</p>
<p>Citigroup returned about $2 billion in buybacks during the quarter and is expected to face significant attention around potential buyback levels of $3-4 billion per quarter in the second half of 2025, Najarian said. Regardless of how much guidance management offers on capital return, the analyst expects the stock to react favorably to the solid PPNR beat.</p>
<h2 class="wp-block-heading"><strong>Keefe, Bruyette &amp; Woods</strong></h2>
<p>McGratty raised its 2025 and 2026 EPS estimates for Citigroup by 5% and 3%, respectively, following a stronger-than-expected second-quarter fiscal 2025 performance and improved guidance. The analyst lifted 2025 EPS to $7.55 from $7.20 and 2026 EPS to $9.75 from $9.50, citing higher revenues and solid execution across key areas.</p>
<p>McGratty noted that Citigroup outperformed the broader bank index by 610 basis points on the day (+3.7% vs. BKX -2.4%), driven by its guidance for at least $4 billion in third-quarter fiscal 2025 buybacks, strong markets and investment banking results, lower net charge-offs (NCOs) in the card business, and continued positive operating leverage.</p>
<p>The analyst noted these developments increase its confidence in Citi reaching its 2026 ROTCE target of 10-11% (KBW estimate: 9.8%), supporting its long-term bullish thesis.</p>
<p>He noted that in the second quarter, NII beat expectations, supported by 3% average loan growth and favorable TTS deposit spreads.</p>
<p>Markets revenue posted the second-best quarter since 2020, rising 16% year-over-year and exceeding mid-quarter guidance, McGratty said. Investment banking also outperformed, growing 13% year-over-year, led by Advisory and ECM strength, the analyst pointed out.</p>
<p>Citi returned $2.0 billion in share buybacks, slightly ahead of KBW&#8217;s $1.8 billion forecast. Meanwhile, he added that branded card NCLs held steady at 3.5-4.0%, and retail services NCLs remained at 5.75–6.25%.</p>
<p>McGratty noted Citi raised its 2025 revenue guidance to ~$84.0 billion (previous: $83.1-$84.1 billion) and now expects NII ex-Markets to grow ~4% Y/Y (prior: 2–3%). The analyst added that Citi maintained expense guidance at ~$53.4 billion, subject to volume and revenue-related shifts.</p>
<p>McGratty emphasized that Citigroup remains the most compelling value play among large-cap banks, trading below tangible book value and best positioned to benefit from potential deregulation. He added that achieving its ROTCE goal by 2026 could be a key rerating catalyst, especially amid continued macro and geopolitical uncertainty.</p>
<p>McGratty noted that despite Citigroup&#8217;s stock being historically inexpensive, he believes near-term catalysts enhance its attractiveness. </p>
<p>He highlighted two primary reasons: First, Citi&#8217;s strong franchise and recent management adjustments position the firm to capitalize on revenue opportunities in investment banking and trading, particularly given expectations for improved market conditions post-election in areas like M&amp;A, ECM, and FICC trading. Second, a potential reduction in regulations could not only alleviate some control and procedure risks for Citi but also offer substantial capital relief, with Citi being the primary beneficiary should the Basel III endgame be relaxed.</p>
<p><strong>Price Action:</strong> Despite the broadly positive analyst sentiment, Citigroup&#8217;s stock was trading lower by 1.71% to $88.48 at last check Wednesday.</p>
<p><strong><em>Read Next:</em></strong></p>
<ul class="wp-block-list">
<li><strong><em><a href="https://www.benzinga.com/markets/large-cap/25/07/46437052/mastercard-launches-ultra-exclusive-card-for-high-spenders" target="_blank" rel="noreferrer noopener">Mastercard Launches New Benefits, Ultra-Exclusive Card For High Spenders</a></em></strong></li>
</ul>
<p><em>Photo by Konektus via Shutterstock</em></p>


Reiteration

Trading Ideas

Why Citigroup Is Still The Best Value Bet In Large-Cap Banking

Macro Economic Events

Economics

Federal Reserve

Fed Beige Book: This Report Was Prepared At The Federal Reserve Bank Of Boston Based On Information Collected On Or Before July 7; Economic Activity Increased Slightly From Late May - Early July; The Outlook Was Neutral To Slightly Pessimistic, As Only Two Districts Expected Activity To Increase, And Others Foresaw Flat Or Slightly Weaker Activity; Prices Increased Across Districts, With Seven Characterizing Price Growth As Moderate And Five Characterizing It As Modest, Mostly Similar To Previous Report

<p>JP Morgan  analyst Bryan Smilek   maintains Coursera (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) with a Neutral and raises the price target from $8 to $9.</p>


COUR

JP Morgan Maintains Neutral on Coursera, Raises Price Target to $9

<p>B. Riley Securities  analyst Alex Rygiel   maintains Bowman Consulting Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWMN#NASDAQ">BWMN</a>) with a Buy and raises the price target from $33 to $43.</p>


BWMN

B. Riley Securities Maintains Buy on Bowman Consulting Group, Raises Price Target to $43

<p>In the preceding three months, 8 analysts have released ratings for Humana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Humana and provided 12-month price targets. The average target is $280.75, accompanied by a high estimate of $310.00 and a low estimate of $260.00. This current average has decreased by 7.0% from the previous average price target of $301.88. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752688869_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Humana. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$260.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Kevin Fischbeck</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$260.00</td>
<td>$320.00</td>
</tr>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$280.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Andrew Mok</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$268.00</td>
<td>$273.00</td>
</tr>
<tr>
<td>Andrew Mok</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$273.00</td>
<td>$322.00</td>
</tr>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$305.00</td>
<td>$325.00</td>
</tr>
<tr>
<td>Sarah James</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$290.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Michael Wiederhorn</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$310.00</td>
<td>$300.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Humana. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Humana compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Humana's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into Humana's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/HUM/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Humana analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Humana</h2>
<p>Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.</p>
<h3>Humana: A Financial Overview</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Humana's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of <strong>8.45%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>3.87%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Humana's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>7.29%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Humana's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>2.55%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Humana's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.75</strong>.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Expert Outlook: Humana Through The Eyes Of 8 Analysts

<p>Ratings for EPR Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPR#NYSE">EPR</a>) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for EPR Props, revealing an average target of $58.0, a high estimate of $65.00, and a low estimate of $53.00. Surpassing the previous average price target of $53.86, the current average has increased by 7.69%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752688859_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>The standing of EPR Props among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Goldsmith</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$62.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Simon Yarmak</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$65.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>John Kilichowski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Underweight</td>
<td>$53.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>RJ Milligan</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$57.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Michael Carroll</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$58.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Ki Bin Kim</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$55.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Michael Goldsmith</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$56.00</td>
<td>$52.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to EPR Props. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of EPR Props compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of EPR Props's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/EPR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on EPR Props analyst ratings.</strong></a></p>
<h2>Discovering EPR Props: A Closer Look</h2>
<p>EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.</p>
<h3>EPR Props: A Financial Overview</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3M period, EPR Props showcased positive performance, achieving a revenue growth rate of <strong>5.29%</strong> as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Real Estate sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> EPR Props's net margin excels beyond industry benchmarks, reaching <strong>36.58%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> EPR Props's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>2.57%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> EPR Props's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>1.07%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>1.3</strong>, EPR Props adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


7 Analysts Have This To Say About EPR Props

<p>In the preceding three months, 4 analysts have released ratings for Kayne Anderson BDC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBDC#NYSE">KBDC</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $16.62, a high estimate of $17.00, and a low estimate of $16.00. Experiencing a 2.24% decline, the current average is now lower than the previous average price target of $17.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752688851_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>The perception of Kayne Anderson BDC by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Doug Harter</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$16.50</td>
<td>$16.00</td>
</tr>
<tr>
<td>Kenneth Lee</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$17.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Kenneth Lee</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$17.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Finian O'Shea</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$16.00</td>
<td>$17.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Kayne Anderson BDC. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Kayne Anderson BDC compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for Kayne Anderson BDC's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Kayne Anderson BDC's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/KBDC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Kayne Anderson BDC analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.</p>
<h2>All You Need to Know About Kayne Anderson BDC</h2>
<p>Kayne Anderson BDC Inc is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company that invests primarily in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through debt investments in middle-market companies.</p>
<h3>Understanding the Numbers: Kayne Anderson BDC's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> Kayne Anderson BDC's revenue growth over a period of 3M has faced challenges. As of 31 March, 2025, the company experienced a revenue decline of approximately <strong>-20.51%</strong>. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.</p>
<p><strong>Net Margin:</strong> Kayne Anderson BDC's net margin excels beyond industry benchmarks, reaching <strong>94.63%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Kayne Anderson BDC's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>1.88%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Kayne Anderson BDC's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>1.03%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.85</strong>, Kayne Anderson BDC adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


KBDC

Beyond The Numbers: 4 Analysts Discuss Kayne Anderson BDC Stock

<p>Deep-pocketed investors have adopted a bullish approach towards Cloudflare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in NET usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 18 extraordinary options activities for Cloudflare. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 50% leaning bullish and 33% bearish. Among these notable options, 4 are puts, totaling $118,255, and 14 are calls, amounting to $1,820,676.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $115.0 to $210.0 for Cloudflare during the past quarter. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In terms of liquidity and interest, the mean open interest for Cloudflare options trades today is 534.27 with a total volume of 1,316.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Cloudflare's big money trades within a strike price range of $115.0 to $210.0 over the last 30 days.</p>
<h3>Cloudflare Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752688845_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>NET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$19.55</td>
<td>$19.05</td>
<td>$19.35</td>
<td>$180.00</td>
<td>$870.7K</td>
<td>1.2K</td>
<td align="right">451</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$94.05</td>
<td>$92.35</td>
<td>$92.8</td>
<td>$115.00</td>
<td>$343.3K</td>
<td>2.1K</td>
<td align="right">37</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/01/25</td>
<td>$10.1</td>
<td>$10.05</td>
<td>$10.1</td>
<td>$195.00</td>
<td>$99.9K</td>
<td>203</td>
<td align="right">1</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$25.2</td>
<td>$24.6</td>
<td>$25.2</td>
<td>$200.00</td>
<td>$78.1K</td>
<td>901</td>
<td align="right">174</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$51.95</td>
<td>$50.35</td>
<td>$51.33</td>
<td>$140.00</td>
<td>$71.8K</td>
<td>721</td>
<td align="right">14</td>
</tr>
</tbody>
</table>
</p>
<h3>About Cloudflare</h3>
<p>Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.</p>
<p>Following our analysis of the options activities associated with Cloudflare, we pivot to a closer look at the company's own performance.</p>
<h3>Where Is Cloudflare Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 1,641,872, with NET's price up by 0.4%, positioned at $187.71.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 15 days.</li>
</ul>
<h3>What The Experts Say On Cloudflare</h3>
<p>Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $222.5.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Outperform rating on Cloudflare with a target price of $220.<br />
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Cloudflare, which currently sits at a price target of $225. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Cloudflare with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Options

Markets

Check Out What Whales Are Doing With NET

<p>Financial giants have made a conspicuous bullish move on Marvell Tech. Our analysis of options history for Marvell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) revealed 41 unusual trades.</p>
<p>Delving into the details, we found 41% of traders were bullish, while 36% showed bearish tendencies. Out of all the trades we spotted, 18 were puts, with a value of $5,337,042, and 23 were calls, valued at $1,017,072.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $35.0 and $85.0 for Marvell Tech, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Marvell Tech's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Marvell Tech's whale activity within a strike price range from $35.0 to $85.0 in the last 30 days. </p>
<h3>Marvell Tech 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752688840_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MRVL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$19.65</td>
<td>$18.75</td>
<td>$18.8</td>
<td>$80.00</td>
<td>$3.7M</td>
<td>1.4K</td>
<td align="right">0</td>
</tr>
<tr>
<td>MRVL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$3.1</td>
<td>$2.91</td>
<td>$2.95</td>
<td>$45.00</td>
<td>$236.0K</td>
<td>2.2K</td>
<td align="right">800</td>
</tr>
<tr>
<td>MRVL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/18/26</td>
<td>$7.25</td>
<td>$7.05</td>
<td>$7.1</td>
<td>$55.00</td>
<td>$165.4K</td>
<td>44</td>
<td align="right">240</td>
</tr>
<tr>
<td>MRVL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$10.95</td>
<td>$10.8</td>
<td>$10.8</td>
<td>$72.50</td>
<td>$154.4K</td>
<td>2.4K</td>
<td align="right">143</td>
</tr>
<tr>
<td>MRVL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/18/26</td>
<td>$14.7</td>
<td>$14.3</td>
<td>$14.35</td>
<td>$70.00</td>
<td>$143.4K</td>
<td>205</td>
<td align="right">100</td>
</tr>
</tbody>
</table>
</p>
<h3>About Marvell Tech</h3>
<p>Marvell Technology is a fabless chip designer focused on wired networking, where it has the second-highest market share. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical and copper transceivers, switches, and storage controllers.</p>
<p>Following our analysis of the options activities associated with Marvell Tech, we pivot to a closer look at the company's own performance.</p>
<h3>Marvell Tech's Current Market Status</h3>
<ul>
<li>With a trading volume of 19,749,646, the price of MRVL is down by -3.98%, reaching $69.53.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 43 days from now.</li>
</ul>
<h3>What The Experts Say On Marvell Tech</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $84.2.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Buy rating for Marvell Tech, targeting a price of $90.<br />
&#x2A; An analyst from Benchmark has revised its rating downward to Buy, adjusting the price target to $95.<br />
&#x2A; An analyst from Goldman Sachs has revised its rating downward to Neutral, adjusting the price target to $75.<br />
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $85.<br />
&#x2A; An analyst from Melius Research persists with their Hold rating on Marvell Tech, maintaining a target price of $76. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Marvell Tech, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


MRVL

Unpacking the Latest Options Trading Trends in Marvell Tech

<p>In the last three months, 4 analysts have published ratings on NNN REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NNN#NYSE">NNN</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated NNN REIT and provided 12-month price targets. The average target is $43.75, accompanied by a high estimate of $46.00 and a low estimate of $42.00. This current average has decreased by 1.13% from the previous average price target of $44.25. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752688839_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive NNN REIT. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Goldsmith</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$42.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>James Kammert</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$44.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Richard Hightower</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$46.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Michael Goldsmith</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$43.00</td>
<td>$44.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to NNN REIT. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of NNN REIT compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for NNN REIT's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of NNN REIT's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/NNN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on NNN REIT analyst ratings.</strong></a></p>
<h2>Discovering NNN REIT: A Closer Look</h2>
<p>NNN REIT Inc is a real estate investment trust that invests in and develops properties throughout the United States. The company generates revenue from leasing properties to tenants, including convenience stores, automotive services, fitness centers, theatres, restaurants, and banks. Rents from convenience stores and restaurants contribute the majority proportion of total revenue. The maximum of the company's properties are located in the South and Southeast of the United States.</p>
<h3>Key Indicators: NNN REIT's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> NNN REIT's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately <strong>7.17%</strong>. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Real Estate sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> NNN REIT's net margin excels beyond industry benchmarks, reaching <strong>41.71%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> NNN REIT's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>2.21%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>1.08%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> NNN REIT's debt-to-equity ratio is below the industry average at <strong>1.03</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Breaking Down NNN REIT: 4 Analysts Share Their Views

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Albemarle</strong>.</p>
<p>Looking at options history for Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) we detected 10 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and 50% with bearish.</p>
<p>From the overall spotted trades, 2 are puts, for a total amount of $162,675 and 8, calls, for a total amount of $299,142.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $55.0 and $100.0 for Albemarle, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Albemarle's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Albemarle's significant trades, within a strike price range of $55.0 to $100.0, over the past month.</p>
<h3>Albemarle 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752688835_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ALB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$10.1</td>
<td>$10.05</td>
<td>$10.05</td>
<td>$70.00</td>
<td>$126.6K</td>
<td>5.6K</td>
<td align="right">163</td>
</tr>
<tr>
<td>ALB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$9.1</td>
<td>$8.0</td>
<td>$9.1</td>
<td>$100.00</td>
<td>$113.7K</td>
<td>987</td>
<td align="right">125</td>
</tr>
<tr>
<td>ALB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$4.1</td>
<td>$4.05</td>
<td>$4.05</td>
<td>$65.00</td>
<td>$36.0K</td>
<td>1.7K</td>
<td align="right">217</td>
</tr>
<tr>
<td>ALB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$7.35</td>
<td>$7.15</td>
<td>$7.27</td>
<td>$80.00</td>
<td>$28.2K</td>
<td>1.9K</td>
<td align="right">146</td>
</tr>
<tr>
<td>ALB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$4.8</td>
<td>$4.65</td>
<td>$4.65</td>
<td>$70.00</td>
<td>$26.9K</td>
<td>616</td>
<td align="right">69</td>
</tr>
</tbody>
</table>
</p>
<h3>About Albemarle</h3>
<p>Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.</p>
<p>Having examined the options trading patterns of Albemarle, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Albemarle's Current Market Status</h3>
<ul>
<li>With a trading volume of 1,208,473, the price of ALB is up by 0.14%, reaching $70.12.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 14 days from now.</li>
</ul>
<h3>Expert Opinions on Albemarle</h3>
<p>Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $73.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from UBS has revised its rating downward to Sell, adjusting the price target to $57.<br />
&#x2A; Consistent in their evaluation, an analyst from Keybanc keeps a Overweight rating on Albemarle with a target price of $87.<br />
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Equal-Weight rating on Albemarle with a target price of $75. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Albemarle with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


A Closer Look at Albemarle's Options Market Dynamics

<p><strong>Camping World Holdings's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWH#NYSE">CWH</a>) short percent of float has risen 5.54% since its last report. The company recently reported that it has <strong>8.41 million shares sold short</strong>, which is 14.09% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 2.94 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>Camping World Holdings Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752688833_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Camping World Holdings has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Camping World Holdings's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Camping World Holdings's peer group average for short interest as a percentage of float is 10.11%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

Peering Into Camping World Holdings's Recent Short Interest

<p>Pennant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PNTG#NASDAQ">PNTG</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $31.5, a high estimate of $35.00, and a low estimate of $28.00. Marking an increase of 0.8%, the current average surpasses the previous average price target of $31.25. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752688829_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive Pennant Gr. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$28.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Raj Kumar</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$35.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Stephen Baxter</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$31.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$32.00</td>
<td>$28.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Pennant Gr. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Pennant Gr compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Pennant Gr's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into Pennant Gr's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/PNTG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Pennant Gr analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.</p>
<h2>Unveiling the Story Behind Pennant Gr</h2>
<p>Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.</p>
<h3>Breaking Down Pennant Gr's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Pennant Gr's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>33.73%</strong> as of 31 March, 2025, showcasing a substantial increase in top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Pennant Gr's net margin excels beyond industry benchmarks, reaching <strong>3.71%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Pennant Gr's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>2.61%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Pennant Gr's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>1.09%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Pennant Gr's debt-to-equity ratio surpasses industry norms, standing at <strong>1.1</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


PNTG

Breaking Down Pennant Gr: 4 Analysts Share Their Views

<p><strong>Insteel Indus</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIIN#NYSE">IIIN</a>) is set to give its latest quarterly earnings report on Thursday, 2025-07-17. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Insteel Indus will report an <strong>earnings per share</strong> (EPS) of $0.69. </p>
<p>Anticipation surrounds Insteel Indus's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Past Earnings Performance</h3>
<p>During the last quarter, the company reported an EPS beat by $0.26, leading to a 0.0% drop in the share price on the subsequent day.</p>
<p>Here's a look at Insteel Indus's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.29</td>
<td>0.09</td>
<td>0.31</td>
<td>0.43</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.55</td>
<td>0.10</td>
<td>0.24</td>
<td>0.34</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>14.000000000000002%</td>
<td>5.0%</td>
<td>-2.0%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752688827_0.png" alt="eps graph" /></p>
<h3>Insteel Indus Share Price Analysis</h3>
<p>Shares of Insteel Indus were trading at $38.59 as of July 15. Over the last 52-week period, shares are up 15.81%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/IIIN/earnings"><strong>To track all earnings releases for Insteel Indus visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

IIIN

Insteel Indus's Earnings Outlook

<p><strong>Extra Space Storage's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXR#NYSE">EXR</a>) short percent of float has risen 10.0% since its last report. The company recently reported that it has <strong>3.59 million shares sold short</strong>, which is 2.31% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 2.98 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>Extra Space Storage Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752688828_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Extra Space Storage has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Extra Space Storage's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Extra Space Storage's peer group average for short interest as a percentage of float is 5.71%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


What's Driving the Market Sentiment Around Extra Space Storage?

<p>In the current market session, <strong>Monolithic Power Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>)</strong> share price is at $703.12, after a <strong>2.02%</strong> decrease. Over the past month, the stock went up by <strong>1.43%</strong>, but over the past year, it actually fell by <strong>16.64%</strong>. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.</p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2025/1752688823_0_0.png" alt="Past Year Chart" /></p>

<h3>Comparing Monolithic Power Systems P/E Against Its Peers</h3>
<p>The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. </p>
<p>Monolithic Power Systems has a lower P/E than the aggregate P/E of <strong>76.4</strong> of the Semiconductors &amp; Semiconductor Equipment industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2025/1752688823_1.png" alt="Guage" /></p>

<p>In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes. </p>


Comments

Surgery Partners

Vendite allo scoperto

Surgery Partners (NASDAQ:SGRY) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO